Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.

BACKGROUND: Previous studies have suggested that baseline computed tomographic (CT) scans might be a useful tool for selecting particular ischemic stroke patients who would benefit from thrombolysis. The aim of the present study was to assess whether the baseline CT scan, assessed with the Alberta...

Full description

Bibliographic Details
Main Authors: Hill, MD, Rowley, H, Adler, F, Eliasziw, M, Furlan, A, Higashida, RT, Wechsler, L, Roberts, H, Dillon, W, Fischbein, N, Firszt, C, Schulz, G, Buchan, A
Format: Journal article
Language:English
Published: 2003
_version_ 1797073394141757440
author Hill, MD
Rowley, H
Adler, F
Eliasziw, M
Furlan, A
Higashida, RT
Wechsler, L
Roberts, H
Dillon, W
Fischbein, N
Firszt, C
Schulz, G
Buchan, A
author_facet Hill, MD
Rowley, H
Adler, F
Eliasziw, M
Furlan, A
Higashida, RT
Wechsler, L
Roberts, H
Dillon, W
Fischbein, N
Firszt, C
Schulz, G
Buchan, A
author_sort Hill, MD
collection OXFORD
description BACKGROUND: Previous studies have suggested that baseline computed tomographic (CT) scans might be a useful tool for selecting particular ischemic stroke patients who would benefit from thrombolysis. The aim of the present study was to assess whether the baseline CT scan, assessed with the Alberta Stroke Program Early CT Score (ASPECTS), could identify ischemic stroke patients who might particularly benefit from intra-arterial thrombolysis of middle cerebral artery occlusion. METHODS: Baseline and 24-hour follow-up CT scans of patients randomized within 6 hours of symptoms to intra-arterial thrombolysis with recombinant pro-urokinase or control in the PROACT-II study were retrospectively scored by using ASPECTS. Patients were stratified into those with ASPECTS >7 or < or =7. Independent functional outcome at 90 days was compared between the 2 strata according to treatment assignment. RESULTS: The analysis included 154 patients with angiographically confirmed middle cerebral artery occlusion. The unadjusted risk ratio of an independent functional outcome, in favor of treatment, in the ASPECTS >7 group was 5.0 (95% confidence interval [CI], 1.3 to 19.2) compared with 1.0 (95% CI, 0.6 to 1.9) in the ASPECTS < or =7 group. After adjustment for baseline characteristics, the risk ratio in the ASPECTS score >7 was 3.2 (95% CI, 1.2 to 9.1). Similar favorable treatment effects were observed when secondary outcomes were used, but these did not reach statistical significance. CONCLUSIONS: Ischemic stroke patients with a baseline ASPECTS >7 were 3 times more likely to have an independent functional outcome with thrombolytic treatment compared with control. Patients with a baseline ASPECTS < or =7 were less likely to benefit from treatment. This observation suggests that ASPECTS can be both a useful clinical tool and an important method of baseline risk stratification in future clinical trials of acute stroke therapy.
first_indexed 2024-03-06T23:21:29Z
format Journal article
id oxford-uuid:68deda65-42ef-4add-aa3e-0165292973ee
institution University of Oxford
language English
last_indexed 2024-03-06T23:21:29Z
publishDate 2003
record_format dspace
spelling oxford-uuid:68deda65-42ef-4add-aa3e-0165292973ee2022-03-26T18:47:49ZSelection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:68deda65-42ef-4add-aa3e-0165292973eeEnglishSymplectic Elements at Oxford2003Hill, MDRowley, HAdler, FEliasziw, MFurlan, AHigashida, RTWechsler, LRoberts, HDillon, WFischbein, NFirszt, CSchulz, GBuchan, A BACKGROUND: Previous studies have suggested that baseline computed tomographic (CT) scans might be a useful tool for selecting particular ischemic stroke patients who would benefit from thrombolysis. The aim of the present study was to assess whether the baseline CT scan, assessed with the Alberta Stroke Program Early CT Score (ASPECTS), could identify ischemic stroke patients who might particularly benefit from intra-arterial thrombolysis of middle cerebral artery occlusion. METHODS: Baseline and 24-hour follow-up CT scans of patients randomized within 6 hours of symptoms to intra-arterial thrombolysis with recombinant pro-urokinase or control in the PROACT-II study were retrospectively scored by using ASPECTS. Patients were stratified into those with ASPECTS >7 or < or =7. Independent functional outcome at 90 days was compared between the 2 strata according to treatment assignment. RESULTS: The analysis included 154 patients with angiographically confirmed middle cerebral artery occlusion. The unadjusted risk ratio of an independent functional outcome, in favor of treatment, in the ASPECTS >7 group was 5.0 (95% confidence interval [CI], 1.3 to 19.2) compared with 1.0 (95% CI, 0.6 to 1.9) in the ASPECTS < or =7 group. After adjustment for baseline characteristics, the risk ratio in the ASPECTS score >7 was 3.2 (95% CI, 1.2 to 9.1). Similar favorable treatment effects were observed when secondary outcomes were used, but these did not reach statistical significance. CONCLUSIONS: Ischemic stroke patients with a baseline ASPECTS >7 were 3 times more likely to have an independent functional outcome with thrombolytic treatment compared with control. Patients with a baseline ASPECTS < or =7 were less likely to benefit from treatment. This observation suggests that ASPECTS can be both a useful clinical tool and an important method of baseline risk stratification in future clinical trials of acute stroke therapy.
spellingShingle Hill, MD
Rowley, H
Adler, F
Eliasziw, M
Furlan, A
Higashida, RT
Wechsler, L
Roberts, H
Dillon, W
Fischbein, N
Firszt, C
Schulz, G
Buchan, A
Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
title Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
title_full Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
title_fullStr Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
title_full_unstemmed Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
title_short Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
title_sort selection of acute ischemic stroke patients for intra arterial thrombolysis with pro urokinase by using aspects
work_keys_str_mv AT hillmd selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT rowleyh selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT adlerf selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT eliasziwm selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT furlana selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT higashidart selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT wechslerl selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT robertsh selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT dillonw selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT fischbeinn selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT firsztc selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT schulzg selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects
AT buchana selectionofacuteischemicstrokepatientsforintraarterialthrombolysiswithprourokinasebyusingaspects